Fewer LAG-3(+) T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes. Jones BE, Maerz MD, Bahnson HT, Somasundaram A, et al. J Immunol 2022 Jan 12. pii: jimmunol.2100850. doi: 10.4049/jimmunol.2100850.

Read + Share

Amedeo Smart

Independent Medical Education

Jones BE, Maerz MD, Bahnson HT, Somasundaram A, et al. Fewer LAG-3(+) T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes. J Immunol 2022 Jan 12. pii: jimmunol.2100850. doi: 10.4049/jimmunol.2100850.
PMID: 35022272